In addition, the pathogenic Yersinia species inhibit TAK1 (Orning et al., 2018; Sarhan et al., 2018), and TAK1 inhibition during Yersinia infection leads to the activation of PANoptosis (Malireddi et al., 2018, 2020). Here, MAP3K7 is linked to Yersinia infectious disease.